Lv11
40 积分 2023-09-04 加入
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
18天前
已完结
A first‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of PF‐06741086, an anti‐tissue factor pathway inhibitor mAb, in healthy volunteers
18天前
已完结
Advances and innovations in haemophilia treatment
18天前
已完结
A Monoclonal Antibody to PACAP for Migraine Prevention
1个月前
已完结
Promising Evidence of Antipsychotic Efficacy without Dopamine D2-Receptor Binding
2个月前
已完结
Error in Results
2个月前
已关闭
Early Onset and Broad Activity of Reproxalap in a Randomized, Double-Masked, Vehicle-Controlled Phase 2b Trial in Dry Eye Disease
2个月前
已完结
A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease
2个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
3个月前
已完结
D100 CDX-0159, AN ANTI-KIT MONOCLONAL ANTIBODY, AS A MODULATOR OF MAST CELL-RELATED DISEASES
3个月前
已关闭
皖公网安备34019202002308
